Efficacy and Safety of Tarlatamab in a Patient With Advanced Delta-Like Ligand 3-Positive Large Cell Neuroendocrine Lung Carcinoma and Untreated Brain Metastases: A Case Report

Eleonora Gariazzo; Sanna Laaksonen; Stephanie Canty; Guilherme Rossato De Almeida; Igor Odintsov; Valentina Santo; Edoardo Garbo; Federica Pecci; Mihaela Aldea; Matthew G. Oser; Lynette Sholl; Jacob M. Sands; Biagio Ricciuti

doi:10.1200/PO-25-00184

Efficacy and Safety of Tarlatamab in a Patient With Advanced Delta-Like Ligand 3-Positive Large Cell Neuroendocrine Lung Carcinoma and Untreated Brain Metastases: A Case Report

Eleonora Gariazzo, Sanna Laaksonen, Stephanie Canty, Guilherme Rossato De Almeida, Igor Odintsov, Valentina Santo, Edoardo Garbo, Federica Pecci, Mihaela Aldea, Matthew G. Oser, Lynette Sholl, Jacob M. Sands, Biagio Ricciuti

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

langue originale	Anglais
Numéro d'article	00184
journal	JCO Precision Oncology
Volume	9
Les DOIs	https://doi.org/10.1200/PO-25-00184
état	Publié - 1 juin 2025
Modification externe	Oui

Accès au document

10.1200/PO-25-00184

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Gariazzo, E., Laaksonen, S., Canty, S., De Almeida, G. R., Odintsov, I., Santo, V., Garbo, E., Pecci, F., Aldea, M., Oser, M. G., Sholl, L., Sands, J. M., & Ricciuti, B. (2025). Efficacy and Safety of Tarlatamab in a Patient With Advanced Delta-Like Ligand 3-Positive Large Cell Neuroendocrine Lung Carcinoma and Untreated Brain Metastases: A Case Report. JCO Precision Oncology, 9, Article 00184. https://doi.org/10.1200/PO-25-00184

@article{a140d966e2134a2f954bcf33522816f7,

title = "Efficacy and Safety of Tarlatamab in a Patient With Advanced Delta-Like Ligand 3-Positive Large Cell Neuroendocrine Lung Carcinoma and Untreated Brain Metastases: A Case Report",

author = "Eleonora Gariazzo and Sanna Laaksonen and Stephanie Canty and {De Almeida}, {Guilherme Rossato} and Igor Odintsov and Valentina Santo and Edoardo Garbo and Federica Pecci and Mihaela Aldea and Oser, {Matthew G.} and Lynette Sholl and Sands, {Jacob M.} and Biagio Ricciuti",

year = "2025",

month = jun,

day = "1",

doi = "10.1200/PO-25-00184",

language = "English",

volume = "9",

journal = "JCO Precision Oncology",

issn = "2473-4284",

}

Gariazzo, E, Laaksonen, S, Canty, S, De Almeida, GR, Odintsov, I, Santo, V, Garbo, E, Pecci, F, Aldea, M, Oser, MG, Sholl, L, Sands, JM & Ricciuti, B 2025, 'Efficacy and Safety of Tarlatamab in a Patient With Advanced Delta-Like Ligand 3-Positive Large Cell Neuroendocrine Lung Carcinoma and Untreated Brain Metastases: A Case Report', JCO Precision Oncology, VOL. 9, 00184. https://doi.org/10.1200/PO-25-00184

Efficacy and Safety of Tarlatamab in a Patient With Advanced Delta-Like Ligand 3-Positive Large Cell Neuroendocrine Lung Carcinoma and Untreated Brain Metastases: A Case Report. / Gariazzo, Eleonora; Laaksonen, Sanna; Canty, Stephanie et al.
Dans: JCO Precision Oncology, Vol 9, 00184, 01.06.2025.

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

TY - JOUR

T1 - Efficacy and Safety of Tarlatamab in a Patient With Advanced Delta-Like Ligand 3-Positive Large Cell Neuroendocrine Lung Carcinoma and Untreated Brain Metastases

T2 - A Case Report

AU - Gariazzo, Eleonora

AU - Laaksonen, Sanna

AU - Canty, Stephanie

AU - De Almeida, Guilherme Rossato

AU - Odintsov, Igor

AU - Santo, Valentina

AU - Garbo, Edoardo

AU - Pecci, Federica

AU - Aldea, Mihaela

AU - Oser, Matthew G.

AU - Sholl, Lynette

AU - Sands, Jacob M.

AU - Ricciuti, Biagio

PY - 2025/6/1

Y1 - 2025/6/1

UR - http://www.scopus.com/inward/record.url?scp=105008377859&partnerID=8YFLogxK

U2 - 10.1200/PO-25-00184

DO - 10.1200/PO-25-00184

M3 - Article

AN - SCOPUS:105008377859

SN - 2473-4284

VL - 9

JO - JCO Precision Oncology

JF - JCO Precision Oncology

M1 - 00184

ER -